SCHEMBL26108154

SCHEMBL26108154

O=C(COc1ccc(N2C(=O)[C@@H]3[C@@H]4C=C[C@@H]([C@H]5C[C@@H]45)[C@@H]3C2=O)cc1)c1ccc(Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ KMT2A Q03164 5/20 0.49
▸ HPGD P15428 1/20 0.47
▸ TRIP13 Q15645 1/20 0.46
▸ MEN1 O00255 4/20 0.45
▸ ATM Q13315 3/20 0.45
▸ KDM4E B2RXH2 3/20 0.45
▸ MAPT P10636 3/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ TNNI3 P19429 1/20 0.43
▸ TNNT2 P45379 1/20 0.43
▸ TNNC1 P63316 1/20 0.43
▸ NPC1 O15118 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ RECQL P46063 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26083642 1.00 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2KMT2AHPGDTRIP13
SCHEMBL26108724 0.90 ATM (0.46) ALDH1A1SMN1; SMN2KMT2AHPGDTRIP13
SCHEMBL26083683 0.90 ATM (0.46) ALDH1A1SMN1; SMN2KMT2AHPGDTRIP13
SCHEMBL26110277 0.90 ALDH1A1 (0.52) ALDH1A1KMT2AHPGDTRIP13MEN1
SCHEMBL26108407 0.89 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2KMT2AHPGDTRIP13
SCHEMBL31466928 0.89 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2KMT2AHPGDTRIP13
SCHEMBL26083644 0.89 ALDH1A1 (0.53) ALDH1A1KMT2AHPGDTRIP13MEN1
SCHEMBL26110309 0.89 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2KMT2AHPGDTRIP13
SCHEMBL31466742 0.89 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2KMT2AHPGDTRIP13
SCHEMBL26108400 0.89 KMT2A (0.52) ALDH1A1KMT2AHPGDTRIP13MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250034091-A1 Small molecule inhibitors of lanosterol synthase BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-01-30 — — US disclosed
WO-2023192782-A2 SMALL MOLECULE INHIBITORS OF LANOSTEROL SYNTHASE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-10-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250034091-A1 Small molecule inhibitors of lanosterol synthase LSS, CYP51A1, CYP27A1 ALDH1A1 3791/4885SMN1; SMN2 119/4885KMT2A 4011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback